TheEdgeResearch
Home / Stocks / BLEG

Branded Legacy, Inc. (BLEG)

OTC Healthcare Biotechnology
$0.07 ▼ -48.57%
Market Cap
$83,382
Sector
Healthcare
Industry
Biotechnology
Beta
1.08
52-Wk Range
0.007-1.2
CEO
Jamie Forrest
Country
US
Currency
USD

Branded Legacy, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Melbourne, FL, US. The stock last traded at $0.07, down 48.57% on the session, giving a market capitalisation of $83,382. On trailing twelve-month figures it carries a trailing P/E of -0.09, a net margin of -209.8%. Its beta of 1.08 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.09
Price / Sales
0.35
Price / Book
-0.37
EV / EBITDA
-4.12
Gross margin
89.2%
Operating margin
-193.2%
Net margin
-209.8%
Return on equity
—
Debt / equity
-0.90
Current ratio
0.12
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
1995-02-01
Headquarters
Melbourne, FL, US
About Branded Legacy, Inc.

Branded Legacy Inc engages in the commercial development of hemp and cannabinoid-infused beverages in Central Florida. It provides CBD topicals and tinctures, and hemp coffees and teas. The company was formerly known as Elev8 Brands, Inc. and changed its name to Branded Legacy Inc in May 2020. Branded Legacy Inc. was incorporated in 1981 and is headquartered in Melbourne, Florida.

Comparable companies

Branded Legacy, Inc. is most often compared with the following Healthcare names:

ALKMAMNCAQPWARRTBLLBDZGHHVCWMTTCFNUVMVGGIF
More research on BLEG
BLEG technical analysis BLEG TheEdge Score Compare against peers
Open full interactive analysis & DCF →